These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 23341308)

  • 141. Evaluation of an Inpatient Postpartum Human Papillomavirus Immunization Program.
    Avni-Singer L; Oliveira CR; Torres A; Shapiro ED; Niccolai LM; Sheth SS
    Obstet Gynecol; 2020 Nov; 136(5):1006-1015. PubMed ID: 33030866
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Health care providers' perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky.
    Head KJ; Vanderpool RC; Mills LA
    Public Health Nurs; 2013 Jul; 30(4):351-60. PubMed ID: 23808860
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Provider communication and HPV vaccine uptake: A meta-analysis and systematic review.
    Oh NL; Biddell CB; Rhodes BE; Brewer NT
    Prev Med; 2021 Jul; 148():106554. PubMed ID: 33857561
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Impact assessment of a provider-targeted national vaccine messaging campaign on human papillomavirus vaccination rates among US adolescent males.
    Agana-Norman DF; Berenson AB; Chang M
    Prev Med; 2022 Nov; 164():107228. PubMed ID: 36057389
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Human papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation.
    Eberth JM; Hossain MM; Tiro JA; Zhang X; Holt JB; Vernon SW
    Womens Health Issues; 2013; 23(2):e131-41. PubMed ID: 23481692
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Human papillomavirus vaccination uptake among Native Hawaiian and Pacific Islander adults in the United States.
    Adjei Boakye E; Stierwalt T; Grundy S; Osazuwa-Peters N; Lee M; Elgee M; Schootman M
    Ann Epidemiol; 2022 Feb; 66():52-55. PubMed ID: 34563569
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Individual- and regional-level determinants of human papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study.
    Remes O; Smith LM; Alvarado-Llano BE; Colley L; Lévesque LE
    BMC Public Health; 2014 Oct; 14():1047. PubMed ID: 25297055
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Human papillomavirus (HPV) vaccination coverage in Brazil: spatial and age cohort heterogeneity.
    Moura LL; Codeço CT; Luz PM
    Rev Bras Epidemiol; 2020; 24():e210001. PubMed ID: 33331411
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Facilitators and Barriers to the Implementation of the HPV VACs (Vaccinate Adolescents Against Cancers) Program: A Consolidated Framework for Implementation Research Analysis.
    Escoffery C; Riehman K; Watson L; Priess AS; Borne MF; Halpin SN; Rhiness C; Wiggins E; Kegler MC
    Prev Chronic Dis; 2019 Jul; 16():E85. PubMed ID: 31274411
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Effective HPV Vaccination Strategies: What Does the Evidence Say? An Integrated Literature Review.
    Holloway GL
    J Pediatr Nurs; 2019; 44():31-41. PubMed ID: 30683279
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine.
    Chang RS; Shing JZ; Erves JC; Du L; Koyama T; Deppen S; Rentuza AB; McAfee C; Stroebel C; Cates J; Harnack L; Andrews D; Bramblett R; Hull PC
    BMC Med Inform Decis Mak; 2022 Dec; 22(1):339. PubMed ID: 36550466
    [TBL] [Abstract][Full Text] [Related]  

  • 152. [Human papillomavirus vaccination available for boys also; information for oral healthcare providers].
    Poelman MR; Brand HS; Jager DHJ; de Visscher JGAM
    Ned Tijdschr Tandheelkd; 2022 Jun; 129(6):281-286. PubMed ID: 35537092
    [TBL] [Abstract][Full Text] [Related]  

  • 153. An opportunity to increase human papillomavirus vaccination rates: Change the guidelines.
    Aragones A; Gany F; Kaplan A; Bruno D
    Hum Vaccin Immunother; 2022 Nov; 18(6):2136444. PubMed ID: 36282533
    [TBL] [Abstract][Full Text] [Related]  

  • 154. A Nationwide Epidemiological Survey of Adolescent Patients With Diverse Symptoms Similar to Those Following Human Papillomavirus Vaccination: Background Prevalence and Incidence for Considering Vaccine Safety in Japan.
    Fukushima W; Hara M; Kitamura Y; Shibata M; Ugawa Y; Hirata K; Oka A; Miyamoto S; Kusunoki S; Kuwabara S; Hashimoto S; Sobue T
    J Epidemiol; 2022 Jan; 32(1):34-43. PubMed ID: 34719583
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Disparities in human papillomavirus vaccine completion among vaccine initiators.
    Chou B; Krill LS; Horton BB; Barat CE; Trimble CL
    Obstet Gynecol; 2011 Jul; 118(1):14-20. PubMed ID: 21691158
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Promoting Strategies to Increase HPV Vaccination in the Pediatric Primary Care Setting.
    Bernstein TA; Broome M; Millman J; Epstein J; Derouin A
    J Pediatr Health Care; 2022; 36(2):e36-e41. PubMed ID: 35120779
    [TBL] [Abstract][Full Text] [Related]  

  • 157. HPV vaccine recommendations by age: A survey of providers in federally qualified health centers.
    Lake P; Fuzzell L; Brownstein NC; Fontenot HB; Michel A; McIntyre M; Whitmer A; Rossi SL; Perkins RB; Vadaparampil ST
    Hum Vaccin Immunother; 2023 Dec; 19(1):2181610. PubMed ID: 36882951
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    Sternjakob-Marthaler A; Berkó-Göttel B; Rissland J; Schöpe J; Taurian E; Müller H; Weber G; Lohse S; Lamberty T; Holleczek B; Stoffel H; Hauptmann G; Giesen M; Firk C; Schanzenbach A; Brandt F; Hohmann H; Werthner Q; Selzer D; Lehr T; Wagenpfeil S; Smola S
    PLoS One; 2022; 17(9):e0273332. PubMed ID: 36054196
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Messaging preferences among Florida caregivers participating in focus groups who had not yet accepted the HPV vaccine for their 11- to 12-year-old child.
    Staras SAS; Bylund CL; Mullis MD; Thompson LA; Hall JM; Hansen MD; Fisher CL
    BMC Public Health; 2022 Dec; 22(1):2413. PubMed ID: 36550434
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017-March 2020.
    Lewis RM; Markowitz LE
    Vaccine; 2022 May; 40(20):2828-2832. PubMed ID: 35393147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.